A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

News

RD-Biotech: laureate “France Relance, volet Résilience”

Date of publication : 04/10/2021

On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.


Selected by the French government as part of the France Relance plan, the project to build a GMP-grade production unit will complement our current R&D grade and "High Quality Grade" ("GMP like") plasmid DNA biomanufacturing capacities, in order to answer the growing of market demand in new therapies.

Construction will soon begin on the Temis Santé site.

 

Link to the article: RD-Biotech: lauréat sur le volet Résilience - santé

  • RD-Biotech: laureate “France Relance, volet Résilience”
    Date of publication : 04/10/2021

    On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.


    Selected...

    Read more
  • Custom antibody biomanufacturing & Autumn discounts
    Date of publication : 13/09/2021
    Contact us for more information! Read more
  • RD-Biotech will participate to the first edition of the Innovative Therapies Days, on October 14 and 15, 2021 in Besancon
    Date of publication : 09/09/2021

    First edition of Innovative Therapies Days on 14 and 15 October 2021 in Besancon (25-France) organized by Innov'Health! The meeting of local and international companies specialized in...

    Read more
  • A new website for RD-Biotech
    Date of publication : 23/08/2021

    We are pleased to inform you that RD-Biotech has launched a brand-new website!

    Find here all of the custom development and biomanufacturing services for plasmids, antibodies, recombinant proteins...

    Read more
  • Biotech Investissement Holding sells its affiliate Diaclone SAS (France) to Medix Biochemica (Finland)
    Date of publication : 15/07/2021

    Biotech Investissement will reinforce its business in the biomanufacturing market and molecular engineering services and sells its affiliate Diaclone SAS to Medix Biochemica. The arrival of Diaclone...

    Read more
  • Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Date of publication : 01/04/2021


    Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell...

    Read more
  • Come and join our team!
    Date of publication : 11/03/2021

    As part of the development of its new GMP plasmid production unit, RD-Biotech is recruiting two new profiles:

    - Technician in Molecular Biology Bioproduction

    - Quality Control Manager

    For...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more